Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B6CA
|
|||
| Former ID |
DNC008264
|
|||
| Drug Name |
4-(2-(pyrrolidin-1-yl)ethyl)pyridine
|
|||
| Synonyms |
67580-65-8; 4-[2-(pyrrolidin-1-yl)ethyl]pyridine; 4-(2-Tetrahydro-1H-pyrrol-1-ylethyl)pyridine; 4-(2-pyrrolidin-1-ylethyl)pyridine; MLS000737070; CHEMBL405070; 4-(2-(pyrrolidin-1-yl)ethyl)pyridine; 4-(2-pyrrolidin-1-yl-ethyl)-pyridine; NSC42776; AC1Q4WU8; AC1Q28PY; AC1L60Z5; SCHEMBL3993201; 4-(2-pyrrolidinylethyl)pyridine; CTK2F7988; DTXSID30285782; MolPort-000-145-638; ZINC163336; HMS2752A23; SBB089201; BDBM50372345; STL324986; NSC-42776; AKOS006227946; VP14627; MCULE-2911571696; 4-(2-PYRROLIDINOETHYL)PYRIDINE; SMR000038089
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H16N2
|
|||
| Canonical SMILES |
C1CCN(C1)CCC2=CC=NC=C2
|
|||
| InChI |
1S/C11H16N2/c1-2-9-13(8-1)10-5-11-3-6-12-7-4-11/h3-4,6-7H,1-2,5,8-10H2
|
|||
| InChIKey |
GNJYGFKCUMGKOY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 67580-65-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series. Bioorg Med Chem Lett. 2008 Jan 1;18(1):355-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.